Soligenix's HyBryte (synthetic hypericin) offers a promising solution as a potential first-line therapy for early-stage CTCL. By addressing this critical gap in care, HyBryte has the potential to ...

The view of midlife crisis as a myth continues to gain traction from new research showing how people differ in life pathways, ...

Sport-related doping is commonly understood with the help of individualistic worldviews based on individual morality, ...